Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1238970.RAuYewsbRlesdkjYemkndcgvYIQwLD1EWhzjZGBgkrYWY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1238970.RAuYewsbRlesdkjYemkndcgvYIQwLD1EWhzjZGBgkrYWY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1238970.RAuYewsbRlesdkjYemkndcgvYIQwLD1EWhzjZGBgkrYWY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1238970.RAuYewsbRlesdkjYemkndcgvYIQwLD1EWhzjZGBgkrYWY130_provenance.
- NP1238970.RAuYewsbRlesdkjYemkndcgvYIQwLD1EWhzjZGBgkrYWY130_assertion description "[Crizotinib (XALKORI?, Pfizer) is a tyrosine kinase inhibitor targeting ALK, MET and ROS1, currently approved for the treatment of adults with ALK-rearranged non-small-cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238970.RAuYewsbRlesdkjYemkndcgvYIQwLD1EWhzjZGBgkrYWY130_provenance.
- NP1238970.RAuYewsbRlesdkjYemkndcgvYIQwLD1EWhzjZGBgkrYWY130_assertion evidence source_evidence_literature NP1238970.RAuYewsbRlesdkjYemkndcgvYIQwLD1EWhzjZGBgkrYWY130_provenance.
- NP1238970.RAuYewsbRlesdkjYemkndcgvYIQwLD1EWhzjZGBgkrYWY130_assertion SIO_000772 25413260 NP1238970.RAuYewsbRlesdkjYemkndcgvYIQwLD1EWhzjZGBgkrYWY130_provenance.
- NP1238970.RAuYewsbRlesdkjYemkndcgvYIQwLD1EWhzjZGBgkrYWY130_assertion wasDerivedFrom befree-2016 NP1238970.RAuYewsbRlesdkjYemkndcgvYIQwLD1EWhzjZGBgkrYWY130_provenance.
- NP1238970.RAuYewsbRlesdkjYemkndcgvYIQwLD1EWhzjZGBgkrYWY130_assertion wasGeneratedBy ECO_0000203 NP1238970.RAuYewsbRlesdkjYemkndcgvYIQwLD1EWhzjZGBgkrYWY130_provenance.
- befree-2016 importedOn "2016-02-19" NP1238970.RAuYewsbRlesdkjYemkndcgvYIQwLD1EWhzjZGBgkrYWY130_provenance.